Physician profile
Edward M Stroh
NPI 1841275914
$1,113.71
in general payments reported to CMS, 2019-2025
12 companies · $166 in 2025
The $166 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $492 · 2021: $16.85 · 2023: $182 · 2024: $256 · 2025: $166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $604.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $604.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $272.07 | 2023-2025 | Ozurdex, Durysta |
| Allergan, INC. | $263.72 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $125.00 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $120.56 | 2019 | |
| Mallinckrodt Hospital Products INC. | $93.52 | 2025 | Acthar |
| Bausch & Lomb Americas INC. | $77.51 | 2023-2024 | Xipere, Visudyne, Vyzulta |
| Apellis Pharmaceuticals, INC. | $49.51 | 2023-2024 | Syfovre |
| Oyster Point Pharma, INC. | $31.26 | 2024 | Tyrvaya |
| Alcon Vision LLC | $23.22 | 2023 | Simbrinza |
| Astellas Pharma US INC | $22.08 | 2024 | Izervay |
| Tarsus Pharmaceuticals, INC. | $19.49 | 2025 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $15.77 | 2023 | Cequa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Stroh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.